European Human Biomonitoring Initiative (HBM4EU) EJP-co fund

The European Human Biomonitoring Initiative (HBM4EU) will generate knowledge to inform the safe management of chemicals to protect human health. The main aim of the initiative is to coordinate and advance human biomonitoring in Europe. HBM4EU will provide better evidence of the actual exposure of citizens to chemicals and the possible health effects to support policy making.

HBM4EU is a joint effort of 28 countries, the European Environment Agency and the European Commission, co-funded under Horizon 2020.

The HBM4EU initiative represents a novel collaboration between scientists and chemical risk assessors and risk managers, including several Commission services, EU agencies and national representatives. The project will build bridges between the research and policy worlds and deliver benefits to society in terms of enhanced chemical safety.

HBM4EU will run for five years, from 2017 to 2021. In developing priorities for HBM4EU under the first annual work plan, the consortium conducted a prioritisation exercise to identify those substances to be the focus of activities. Additional rounds of prioritisation will be carried out during the project lifespan to ensure that our research responds dynamically to policy needs.

Home / About RIVM / Mission and strategy / International Affairs / International Projects / European Human Biomonitoring Initiative (HBM4EU) EJP-co fund

RIVM Committed to health and sustainability
Menu